Hepatitis B reactivation in patients with hepatitis B core antibody positive and surface antigen negative on immunosuppressants

doi:10.13105/wjma.v7.i5.209

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7213)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

290

WORD

218

HTML

4606

Figures (1-1)

215

Tables (1-2)

160

Sum=5489

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

781

Download

943

Sum=1724

May 31, 2019 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Meta-Anal. May 31, 2019; 7(5): 209-217
Published online May 31, 2019. doi: 10.13105/wjma.v7.i5.209

Open in New Tab Full Size Figure Download Figure

Figure 1 Treatment algorithm for HBsAg negative, anti-HBc positive patients undergoing immunosuppression. Future research may help determine whether HBcrAg has a role in determining whether patients with HBsAg negative with anti-HBc positive with undetectable DNA undergo HBV chemoprophylaxis or “on-demand” treatment. HBV: Hepatitis B virus.

Citation: Wu CCH, Kumar R. Hepatitis B reactivation in patients with hepatitis B core antibody positive and surface antigen negative on immunosuppressants. World J Meta-Anal 2019; 7(5): 209-217
URL: https://www.wjgnet.com/2308-3840/full/v7/i5/209.htm
DOI: https://dx.doi.org/10.13105/wjma.v7.i5.209